| Study name |
St PETER HIV |
| Methods |
Randomized controlled trial |
| Participants |
HIV‐positive adults with heavy drinking, heavy smoking, a stable resident and telephone number, and interested in cutting down/quitting tobacco or alcohol |
| Interventions |
A) Varenicline + Nicotine Replacement Therapy Placebo; B) Varenicline Placebo + Nicotine Replacement Therapy; C) Cytisine + Nicotine Replacement Therapy Placebo; D) Cystine Placebo + Nicotine Replacement Therapy |
| Outcomes |
Heavy drinking days, alcohol craving, smoking cessation, coronary heart disease risk, mortality risk, cigarettes per day, hsCRP levels, IL‐6 levels |
| Starting date |
July 19, 2017 |
| Contact information |
Jeffery Samet |
| Notes |
None |
